Dr Selisha Sookla, 34, is helping unlock the potential of biotechnology to tackle one of medicine's greatest challenges: the discovery of new cancer treatments. As a senior lecturer at the University of South Africa (UNISA), she combines pioneering research in biocatalysis and anticancer drug discovery with a passion for developing the next generation of South African scientists. Holding a PhD in Microbiology and Biotechnology, Sooklal leads a research laboratory focused on developing innovative biocatalysts and novel anticancer drug candidates. Her research has resulted in two patented anticancer drug candidates with commercial potential, earning her and her co-inventors three UNISA Research Excellence Awards in 2025. These collaborations have strengthened global partnerships while introducing advanced research methodologies to her laboratory in South Africa.